Search for Clinical Trial Results
Porphyria, Erythropoietic - 37 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Studies in Porphyria I: Characterization of Enzyme Defects Condition: Porphyria Date: 1999-10-18 |
Completed |
Study Name: Study of Nutritional Factors in Porphyria Condition: Porphyria Date: 2000-02-24 |
Completed |
Study Name: Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias Condition: Porphyria Date: 1999-10-18 Interventions:
|
Completed |
Study Name: Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks Condition: Porphyria Date: 1999-10-18 Interventions: Drug: luteinizing hormone-releasing factor |
Completed |
Study Name: Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria Condition: Porphyria Date: 2000-02-24 Interventions:
|
Completed |
Study Name: Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria Condition: Porphyria Date: 1999-10-18 Interventions:
|
Completed |
Study Name: Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria Condition: Porphyria Date: 1999-10-18 Interventions:
|
Active, not recruiting |
Study Name: EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP) Condition: Acute Hepatic Porphyria Date: 2014-09-11 |
Enrolling by invitation |
Study Name: Acute Porphyria Biomarkers Condition:
Interventions: Drug: Hemin Hemin will be administered under a separate protocol or for clinical treatment, and samples |
Enrolling by invitation |
Study Name: Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda Condition: Porphyria Cutanea Tarda Date: 2011-01-26 Interventions: Drug: Exjade Orodispersible Tablet, 10 mg/Kg/day ± 5 mg/Kg/day during 24 weeks Deferasirox should b |